GEN Exclusives

More »

GEN Exclusives

More »
Jan 31, 2014

INFOGRAPHIC: Printing the Human Body

See how bioprinting works and why it's so promising.

INFOGRAPHIC: Printing the Human Body

Check out the infographic below for more on this potentially revolutionary process.

  • Printing technology has come a long way in the 21st century, moving swiftly from two dimensional into the realm of 3D. Furniture, cars, shoes, a replica of King Tutankhamun—these are all things that have been made with 3D printing technology. However, it doesn’t stop at material objects. In fact, using modified printer cartridges and extracted cells as the basis, scientists have a discovered a way in which to print human tissue. While this amazing concept is still at an early stage, the future of bioprinting (as it’s commonly known) will allow for full organs and other human parts to be printed on demand for patients. Such a possibility will eventually wipe out the need for donor organs, which is a problem today considering the vast amount of patients in need of new organs.

    The creative team at PrinterInks decided to develop an infographic about this hot topic with the help of start-up Organovo. Using Organovo’s expertise, it developed an infographic to portray how the process works, as well as highlight today’s organ transplant figures and the importance of how much money is concentrated on research and development for drug testing each year.

    Bioprinting infographic

    Created by Printerinks with assistance from Organovo

    How long do you think it will be before a bioprinted organ is first transplanted into a human patient?

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »


Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?